1. Home
  2. INM vs AKAN Comparison

INM vs AKAN Comparison

Compare INM & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • AKAN
  • Stock Information
  • Founded
  • INM 1981
  • AKAN 2021
  • Country
  • INM Canada
  • AKAN Canada
  • Employees
  • INM N/A
  • AKAN N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • AKAN Medicinal Chemicals and Botanical Products
  • Sector
  • INM Health Care
  • AKAN Health Care
  • Exchange
  • INM Nasdaq
  • AKAN Nasdaq
  • Market Cap
  • INM 3.2M
  • AKAN 2.9M
  • IPO Year
  • INM N/A
  • AKAN 2022
  • Fundamental
  • Price
  • INM $2.31
  • AKAN $1.05
  • Analyst Decision
  • INM
  • AKAN
  • Analyst Count
  • INM 0
  • AKAN 0
  • Target Price
  • INM N/A
  • AKAN N/A
  • AVG Volume (30 Days)
  • INM 145.5K
  • AKAN 482.2K
  • Earning Date
  • INM 09-29-2025
  • AKAN 08-12-2025
  • Dividend Yield
  • INM N/A
  • AKAN N/A
  • EPS Growth
  • INM N/A
  • AKAN N/A
  • EPS
  • INM N/A
  • AKAN N/A
  • Revenue
  • INM $4,920,990.00
  • AKAN $836,664.00
  • Revenue This Year
  • INM N/A
  • AKAN N/A
  • Revenue Next Year
  • INM N/A
  • AKAN N/A
  • P/E Ratio
  • INM N/A
  • AKAN N/A
  • Revenue Growth
  • INM N/A
  • AKAN 97.47
  • 52 Week Low
  • INM $1.72
  • AKAN $0.93
  • 52 Week High
  • INM $15.70
  • AKAN $3.20
  • Technical
  • Relative Strength Index (RSI)
  • INM 36.26
  • AKAN 36.71
  • Support Level
  • INM $2.31
  • AKAN $1.00
  • Resistance Level
  • INM $2.71
  • AKAN $1.72
  • Average True Range (ATR)
  • INM 0.10
  • AKAN 0.15
  • MACD
  • INM -0.04
  • AKAN -0.03
  • Stochastic Oscillator
  • INM 2.22
  • AKAN 6.96

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.

Share on Social Networks: